22nd Century Group, Inc.
(NYSE Amex Equities : XXII)

( )
XXII PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.80%61.580.0%$914.89m
NVAXNovavax, Inc. -5.99%98.30102.0%$790.47m
AMGNAmgen, Inc. -0.62%251.591.3%$725.25m
REGNRegeneron Pharmaceuticals, Inc. -0.08%640.342.5%$677.64m
GILDGilead Sciences, Inc. -1.06%75.611.0%$627.17m
BIIBBiogen, Inc. 4.41%280.191.6%$622.60m
VRTXVertex Pharmaceuticals, Inc. -1.05%295.921.9%$509.00m
ILMNIllumina, Inc. -0.61%369.873.5%$300.06m
ALXNAlexion Pharmaceuticals, Inc. -3.97%108.002.0%$219.47m
BMRNBioMarin Pharmaceutical, Inc. 0.59%128.734.3%$214.30m
SGENSeattle Genetics, Inc. -0.35%175.536.1%$200.21m
SRNESorrento Therapeutics, Inc. -1.22%7.291.8%$180.15m
IMMUImmunomedics, Inc. 0.95%41.5511.0%$179.47m
SRPTSarepta Therapeutics, Inc. 3.82%170.1513.9%$164.96m
ALNYAlnylam Pharmaceuticals, Inc. 0.26%160.428.5%$164.06m

Company Profile

22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.